Featuring a slide presentation and related discussion from Dr Ruben Mesa, including the following topics:
- Efficacy and safety of FDA-approved JAK inhibitors for the management of myelofibrosis (MF) (0:00)
- Emerging JAK inhibitors under Phase III evaluation for MF (6:59)
- Current guidelines and strategies for managing MF (13:53)
- Emerging data with novel agents and strategies for MF (17:31)
- Splenic response and symptomology in patients with MF (25:36)
Fler avsnitt av Research To Practice | Oncology Videos
Visa alla avsnitt av Research To Practice | Oncology VideosResearch To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
